Resolution of Amisulpride associated Amenorrhea by Switching to Aripiprazole

Objective: To report a 4-case series in which amisulpride-induced symptomatic hyperprolactinemia was resolved by switching to aripiprazole. Case Reports: Four female patients developed symptomatic hyperprolactinemia such as amenorrhea and/or galactorrhea with elevated serum prolactin levels (113.7 230.0 ng/mL) after taking amisulpride (200-800 mg/day). To resolve the problem of symptomatic hyperprolactinemia, reducing the dosage of amisulpride was first tried, however this approach turned out to have no effect. Subsequently, all 4 patients were switched from amisulpride to aripiprazole (10 20 mg/day), upon which their regular menstrual cycles returned and galactorrhea improved, with the normalization of their serum prolactin levels (6.5 15.0 ng/mL) within 4 weeks after switching Conclusion: Switching to aripiprazole, a partial dopamine agonist, is an effective strategy for the resolution of antipsychotic-induced hyperprolactinemia and associated adverse effects.